key: cord-0848455-o7x6nuvt
authors: Jude, Edward B
title: Response to Letter to the Editor From Speeckaert et al: “Vitamin D Deficiency Is Associated With Higher Hospitalisation Risk from COVID-19: A Retrospective Case-Control Study”
date: 2021-09-16
journal: J Clin Endocrinol Metab
DOI: 10.1210/clinem/dgab607
sha: 40e353a7ddc224b4481d8ab3afaadae48cb56333
doc_id: 848455
cord_uid: o7x6nuvt

nan

We thank the authors for their interest in our recent publication, "Vitamin D deficiency Is Associated With Higher Hospitalization Risk From COVID 19: A Retrospective Case-Control Study" (1). We agree that vitamin D binding protein (DBP) polymorphisms may possibly influence both our results and those of others.

Unfortunately, given that DBP polymorphisms are not routinely checked in UK clinical practice and our study participants were collected from a retrospective database of both community patients and COVID-19 hospital admissions, we cannot say for certain whether this is the case. Furthermore, there are no extant samples available for retrospective genotyping.

There may be a case for future studies involving genotyping for DBP polymorphisms in COVID-19 patients to draw more concrete conclusions between serum 25-hydroxyvitamin D 3 levels, underlying genetics, and COVID-19 severity. However, these conclusions are outside the scope of our study to which Speeckaert et al refers.

Vitamin D deficiency is associated with higher hospitalization risk from COVID-19: A retrospective case-control study